JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB257722

Human SYNJ1 (Synaptojanin) knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

SYNJ1 KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon3.
1 Images
Sanger Sequencing - Human SYNJ1 (Synaptojanin) knockout HeLa cell lysate (AB257722)
  • Sanger seq

Unknown

Sanger Sequencing - Human SYNJ1 (Synaptojanin) knockout HeLa cell lysate (AB257722)

Homozygous : 1 bp insertion in exon3

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon3.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab257722-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human SYNJ1 knockout HeLa cell lysate", "number":"AB257722-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB257722-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
SYNJ1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Synaptojanin also known as SYNJ is a phosphoinositide phosphatase enzyme with a typical molecular mass of around 150 kDa. It functions mechanically by dephosphorylating phosphatidylinositol phosphates at various positions playing an important role in membrane curvature and endocytosis. Its expression is remarkably high in the brain especially in nerve terminals where it assists in synaptic vesicle recycling and neurotransmitter release. Synaptojanin expression also occurs in other tissues but at lower levels.
Biological function summary

Synaptojanin modulates synaptic function and plasticity through its role in lipid metabolism. It is part of a complex with endocytic proteins such as endophilin and dynamin which facilitates the uncoating of clathrin-coated vesicles following endocytosis. This complex action is important for maintaining synaptic efficiency and adaptability especially during high rates of synaptic activity. The disruption of synaptojanin's role affects the proper balance of phospholipids impacting neural communication and function.

Pathways

Synaptojanin plays a significant role in the phosphoinositide signaling and endocytic pathways. It works closely with other proteins like phosphatidylinositol-45-bisphosphate (PIP2) and adaptor protein 2 regulating membrane trafficking and the recycling of synaptic vesicles. These pathways are central to maintaining cellular homeostasis and ensuring neurotransmitter release and recycling occur effectively allowing cells to respond swiftly to dynamic signaling requirements.

Researchers link synaptojanin to neurological conditions like Parkinson's disease and Charcot-Marie-Tooth disease. Mutations in synaptojanin or its interaction partners such as endophilin have been shown to disrupt synaptic vesicle reformation leading to neurodegeneration. Studies suggest that variants in synaptojanin can result in synaptic dysfunction contributing to the pathophysiology of these disorders. Understanding synaptojanin's function helps in the development of therapeutic strategies for related neurodegenerative diseases.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com